Actual medication label and appearance may vary
Peptide Treatment
Wolverine Blend (BPC-157 + TB-500)
Choose a treatment option
The “Wolverine Injection” is a peptide-based formulation that combines BPC-157 and TB-500, two compounds being studied for their potential regenerative and anti-inflammatory effects. Together they may support tissue repair, help reduce inflammation, and assist recovery after injury, surgery, or overuse.
Check eligibilityThis formulation is not FDA-approved to diagnose, treat, cure, or prevent any disease or medical illness.
Why it works
Key benefits
- Faster recovery from sports injuries or post-surgical tissue strain
- Reduced inflammation and discomfort
- Enhanced joint, tendon, and ligament repair
- Improved muscle recovery, flexibility, and endurance
- Support for gut lining and nerve health
Based on early and preclinical data
Mechanism
How it works
BPC-157 (Body Protection Compound-157): A synthetic peptide derived from a natural gastric protein. In preclinical models, it promotes the repair of muscles, tendons, ligaments, and nerves, enhances local blood flow, and reduces inflammation. TB-500 (Thymosin Beta-4): A naturally occurring protein fragment present in most human and animal cells. It supports cell migration, angiogenesis (formation of new blood vessels), and tissue remodeling, helping damaged tissue regain function and flexibility. Together, these peptides may act as a coordinated “repair signal,” accelerating recovery and supporting cellular regeneration, though evidence in humans is still limited.
Frequently asked questions
FAQs
Some patients report improvement in discomfort or mobility within 1–2 weeks, while optimal effects often take 4–6 weeks. Results vary depending on injury type, dose, and concurrent rehabilitation. Continue physical therapy or prescribed exercises for best outcomes.
Most users tolerate peptide therapy well. Mild effects may include: Temporary redness or irritation at the injection site Headache or mild fatigue Rare: nausea or lightheadedness
Before you begin
Informed Consent & Safety
Report persistent or unusual symptoms to your provider. Long-term human safety data are limited.
Research & Studies
Evidence at a Glance
- 1.
Sikiric P et al. Pharmacol Res (2020). – BPC-157 and healing.
- 2.
Gajovic S et al. Front Pharmacol (2023). – BPC-157 in orthopaedic and sports medicine.
- 3.
Skutek M et al. Pharmaceutics (2023). – Multifunctionality of BPC-157.
- 4.
Smart N et al. Ann N Y Acad Sci (2011). – Thymosin β4: multi-functional regenerative peptide. 5. Wan Y et al. Front Bioeng Biotechnol (2022) – Thymosin β4 for tissue regeneration.
Interested in Wolverine Blend (BPC-157 + TB-500)?
Take a short assessment and a licensed provider will review if this treatment is right for you.
Clinical Guidance Disclaimer
The information provided in this document is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. It should never replace sound clinical judgment or personalized advice of a qualified healthcare professional. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read in these materials.
Liability & Indemnification
By utilizing this information, the user acknowledges and agrees that REBL and its affiliates, providers, and staff are not liable for any direct, indirect, or consequential damages resulting from the use or misuse of the information provided herein. Any reliance on the materials contained in this document is solely at the user's own risk.
Regulatory Status
BPC-157 and TB-500 are compounded research peptides, not FDA-approved for any medical indication. They are manufactured by licensed 503A/503B pharmacies for clinical research or wellness use under professional supervision.
Proprietary Rights & Use Restrictions
This document and its contents are the proprietary property of REBL. Unauthorized use, duplication, reproduction, or distribution of these materials—in whole or in part—without express written consent is strictly prohibited.